KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Current Deferred Revenue (2016 - 2022)

Historic Current Deferred Revenue for Dynavax Technologies (DVAX) over the last 11 years, with Q3 2022 value amounting to $87.4 million.

  • Dynavax Technologies' Current Deferred Revenue fell 7562.8% to $87.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $87.4 million, marking a year-over-year decrease of 7562.8%. This contributed to the annual value of $349.9 million for FY2021, which is 81558.67% up from last year.
  • Latest data reveals that Dynavax Technologies reported Current Deferred Revenue of $87.4 million as of Q3 2022, which was down 7562.8% from $192.0 million recorded in Q2 2022.
  • In the past 5 years, Dynavax Technologies' Current Deferred Revenue registered a high of $358.6 million during Q3 2021, and its lowest value of $21.7 million during Q3 2020.
  • Its 3-year average for Current Deferred Revenue is $171.4 million, with a median of $129.6 million in 2021.
  • In the last 5 years, Dynavax Technologies' Current Deferred Revenue skyrocketed by 155156.6% in 2021 and then crashed by 7562.8% in 2022.
  • Over the past 3 years, Dynavax Technologies' Current Deferred Revenue (Quarter) stood at $38.2 million in 2020, then surged by 815.59% to $349.9 million in 2021, then plummeted by 75.02% to $87.4 million in 2022.
  • Its last three reported values are $87.4 million in Q3 2022, $192.0 million for Q2 2022, and $313.2 million during Q1 2022.